Gbs Inc GBS:NASDAQ

RT Quote | NASDAQ | USD
Last | 02/24/21 EST
6.66quote price arrow up+0.20 (+3.10%)
Volume
163,337
52 week range
6.37 - 14.24

...

Loading . . .

KEY STATS

  • Open6.60
  • Day High6.86
  • Day Low6.48
  • Prev Close6.66
  • 52 Week High14.24
  • 52 Week High Date12/23/20
  • 52 Week Low6.37
  • 52 Week Low Date02/17/21
  • Market Cap
  • Shares Out10.42M
  • 10 Day Average Volume0.88M
  • Dividend-
  • Dividend Yield-
  • Beta
  • 1 Year % Change-

RATIOS/PROFITABILITY

  • EPS (TTM)-
  • P/E (TTM)-
  • Fwd P/E (NTM)-
  • EBITDA (MRQ)-
  • ROE (MRQ)-
  • Revenue (MRQ)-
  • Gross Margin (MRQ)-
  • Net Margin (MRQ)-
  • Debt To Equity (MRQ)-

EVENTS

  • Earnings Date-
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest Gbs Inc News

There is no recent news for this security.

Latest GBS News From Our Partners

There is no recent news for this security.

QUOTE FINDER

Profile

MORE
GBS Inc. is a biosensor diagnostic technology company. The Company develops and commercializes a range of biosensor-based point of care (POCT) diagnostic tests that are developed in the modalities of clinical chemistry, immunology, tumor markers, allergens and endocrinology. Its flagship product candidate is the Saliva Glucose Biosensor (SGB), a POCT designed to substitute the finger pricking invasive blood glucose monitoring for diabetic patients. SGB uses saliva to measure...
Address
733 Third Avenue
New York, NY
10017
United States